Prognostic role of Ca125 response criteria and RECIST criteria: Analysis of results from the MITO-3 phase III trial of gemcitabine versus pegylated liposomal doxorubicin in recurrent ovarian cancer

Gabriella Ferrandina, Manuela Ludovisi, Giacomo Corrado, Vito Carone, Marco Petrillo, Giovanni Scambia

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Prognostic role of Ca125 response criteria and RECIST criteria: Analysis of results from the MITO-3 phase III trial of gemcitabine versus pegylated liposomal doxorubicin in recurrent ovarian cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences